Treatment of Graves´Ophthalmopathy With Simvastatin (GO-DS)
Status:
Recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
In an investigator initiated multicenter trial (Malmö, Odense, Århus) the investigators aim
at evaluating activity of Graves´ophthalmopathy (GO) and progress to severe GO in patients
with mild to moderate Graves´ ophthalmopathy treated with simvastatin or no treatment.